These 3 Stocks With Fast-Growing Dividends Can Help You Beat Inflation

The article highlights Eli Lilly, Parker-Hannifin, and Microsoft as dividend growth names with 50%+ dividend increases over five years, EPS growth of 100%+ in each case, and payout ratios below 27%. Lilly raised its dividend 15.3% to $1.73 quarterly, Parker-Hannifin lifted its dividend 11% to $2 and has 71 straight years of increases, and Microsoft increased its dividend 10% to $0.91 while continuing to benefit from AI-driven cloud growth. Lilly also reported Q1 revenue of $19.8B, up 56%, and EPS of $8.55, up 156%, alongside raised long-term revenue and EPS expectations.

Analysis

The common thread here is not “high-quality dividend growth” but balance-sheet optionality created by structurally high incremental margins. PH and MSFT can lift payouts aggressively because each additional dollar of revenue converts unusually well into free cash flow, which means dividend growth is really a byproduct of operating leverage rather than capital-return policy. That matters because these names are less likely to be forced into a payout slowdown in a mild downturn than mature dividend aristocrats with slower top-line growth and higher capital intensity.

For PH, the underappreciated second-order effect is that it is a levered beneficiary of industrial capex normalization without needing a full-cycle manufacturing boom. Near-shoring, electrification, and aerospace all require long lead times and tight qualification standards, which tends to create pricing persistence even if volumes wobble for a quarter or two. That makes PH better expressed as a medium-duration quality cyclical than a pure income stock; the dividend is the evidence of pricing power, not the thesis.

MSFT’s dividend profile is still being misread by income investors as “too low yield to matter,” but the real signal is that the company can keep raising capital returns while funding an AI capex arms race. The market is effectively paying for near-term infrastructure spend and underpricing the durability of software annuity revenue once AI copilots and cloud workloads are embedded. The main risk is not earnings volatility but a multiquarter digestion phase if AI monetization lags capex growth, which could compress sentiment before fundamentals break.

The contrarian angle on both names is that consensus may be overpaying for perceived certainty: dividend growth alone does not make them bond substitutes. If rates stay higher for longer, the relative valuation support for low-yield compounders weakens, and the stocks need continued estimate revisions to hold multiples. That argues for owning them on pullbacks or via options structures rather than chasing them after dividend headlines.

Key Decisions for Investors

• Go long PH on any 3-5% pullback over the next 2-6 weeks; target a 12-month hold where mid-single-digit multiple expansion plus dividend growth can deliver low-teens total return, with downside cushioned by recurring FCF.
• Use MSFT as a quality AI compounder, but prefer staggered entries or 6-12 month call spreads rather than outright chasing; the risk/reward improves if the market sells off on capex fears before AI revenue ramps.
• Pair trade: long MSFT / short a lower-quality mega-cap software name with weaker cash conversion for 3-6 months; the trade benefits if investors continue rewarding self-funded AI spend and punishing stories dependent on external financing.
• Do not treat either name as a pure income substitute at current yields; if the goal is current cash yield, rotate only partial capital and keep dry powder for a rates-driven reset.
• Watch for any guidance cut tied to industrial orders at PH or AI monetization commentary at MSFT; either would be the clearest catalyst to reduce exposure, because the thesis depends on sustained cash conversion, not just dividend growth optics.